Abstract:Retinopathy of prematurity (ROP) is a leading cause of childhood blindness in preterm infants. The incidence of ROP varies widely across countries, with rates as high as 30% in some regions. This study investigated the incidence, risk factors, treatment, and mortality of ROP patients in Germany. Data were extracted from the German Federal Statistical Office (Destatis) diagnosis-related group (DRG) and Institute for the Remuneration System in Hospitals (InEK) databases. Patients with a secondary diagnosis of ROP (ICD-10 code H35.1) in the first 28 days of life were included. Data were extracted for patients admitted between January 1, 2019 and December 31, 2019. The diagnoses and procedures were determined using the German version of the International Classification of Diseases (ICD-10-GM) and the German procedure coding system (OPS). The codes 5-154.xx, 5-155.xx, 8-020.xx, 5-156.9, 6-003.(c&d), 6-007.(2&8) were utilised to denote different ocular treatments. Patient Clinical Complexity Levels were extracted and used to compare ROP with non-ROP patients. A total of 1326 patients with ROP were identified. The incidence of ROP is estimated to be 17.04 per 10,000 live births. The incidence was highest in infants with birth weights less than 500 g and decreased with increasing birth weight. The most common risk factors for ROP were low birth weight, male sex, and prematurity. Of the infants with ROP, 7.2% required ocular treatment. The most common treatment was intraocular injections, followed by photocoagulation. No surgical treatment was required for any of the infants during the study period. The mortality rate for infants with ROP was 60.33 per 10,000. This is higher than the overall neonatal death rate of 24.2 per 10,000. Conclusions: This study found that the incidence of ROP in Germany is similar to that in other developed countries. The study also found that the mortality rate for infants with ROP is higher than the overall neonatal death rate. These findings highlight the importance of early detection and treatment of ROP in preterm infants. What is known: • ROP is a severe eye condition often affecting preterm infants. • Previous data are limited in scope and generalizability. What is new: • Based on a national database, our study found ROP incidence to be 17.04 per 10,000 new births, higher in males (17.71) than in females (16.34). • 7.2% of ROP cases required ocular treatment, inversely correlated with birth weight. • High rates of multimorbidity such as neonatal jaundice (84.69%), respiratory distress syndrome (80.84%), and apnea (78.88%) were observed.

Hyperbilirubinemia and retinopathy of prematurity: a retrospective cohort study

Neonatal hyperbilirubinemia and Rhesus disease of the newborn: incidence and impairment estimates for 2010 at regional and global levels.

Bilirubinemia and retinopathy of prematurity in infants ≤ 29 weeks' gestational age

[Evaluation of Risk Factors for Retinopathy of Prematurity].

Incidence and Risk Factor Analysis of Retinopathy of Prematurity

Increased risk of retinopathy of prematurity since increased O2 saturation targets: A multi-centre study

Global Prevalence and Severity of Retinopathy of Prematurity over the Last Four Decades (1985–2021): A Systematic Review and Meta-Analysis

Evaluation of pro-oxidant antioxidant balance in retinopathy of prematurity

Progress in the study of association between hematological indicators and retinopathy of prematurity (Review)

Retinopathy of Prematurity—Targeting Hypoxic and Redox Signaling Pathways

Biomarkers in retinopathy of prematurity: a systematic review and meta-analysis

Effect of Optimizing Oxygen Saturation Targets on the Incidence of Retinopathy of Prematurity in a Quaternary NICU

Incidence, Risk Factors and Development of Retinopathy of Prematurity in Mid-Preterm and Late-Preterm Infants

Predictive role of systemic immune-inflammation index and neutrophil/lymphocyte ratio values in infants with retinopathy of prematurity

Association of Cardiovascular Disease with Retinopathy of Prematurity

The U.S. National Trend for Retinopathy of Prematurity

Retinopathy of prematurity: contribution of inflammatory and genetic factors

Incidence of Retinopathy of Prematurity Treatment in Extremely Preterm Infants in China.

The incidence of retinopathy of prematurity in neonates in Germany in 2019; a nationwide epidemiological cohort study

Incidence, Risk Factors, and Treatment Outcomes in a Tertiary Care Center

Oxygen saturation levels and retinopathy of prematurity in extremely preterm infants - a case control study